MedTrace Logo

Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults

NCT06236243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-11-27

No results posted yet for this study

Summary

The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

Korean Red Ginseng Extract Powder 120 mg/tablet

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.

DIETARY_SUPPLEMENT

Korean Red Ginseng Extract Powder 500 mg/tablet

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Participants will take 2 tablets 2 times daily (preferably after breakfast and after dinner) for 12 weeks.

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Korea Ginseng Corporation

    lead INDUSTRY

Principal Investigators

  • Amir H.S. Rafie, MD · Valiance Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-09-25
Completion
2024-09-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06236243 on ClinicalTrials.gov